Navigation Links
Solve Skin Conditions and Receive Hair Loss Treatment from Home with New Line of Medical Devices Called Dermaray
Date:8/30/2009

Using state-of-the-art phototherapy technology, Dermaray UV can minimize the effects from skin conditions, while the Dermaray Laser is designed to be a leading home hair loss treatment solution.

(PRWEB) August 30, 2009 -- TCG Industrial Australia, a leader in providing solutions for skin conditions and hair loss treatment options, are pleased to announce the introduction of the Dermaray range of home phototherapy medical devices.

Dermaray systems are designed, constructed and tested in Australia under ISO international quality control standards and supplied with an industry first transferable two year factory warranty. All Dermaray systems feature a unique safety proximity detection system that is able to activate and deactivate the system if unsafe usage is detected providing unparalleled safety to the user.

Dermaray UV is a narrow band UVB-311nm hand held, battery operated and computer controlled medical device for the treatment of chronic skin conditions such as psoriasis, vitiligo, acne and atopic dermatitis. It boasts many unique safety features, plus an innovative and intuitive computer operating system that calculates and manages up to 10 individual patients with up to 32 treatment areas in each treatment program.

Psoriasis is a chronic, non-contagious autoimmune disease which affects the skin and joints. It commonly causes red scaly patches to appear on the skin. UVB has been used to treat psoriasis for more than 75 years. UVB has been the phototherapy of choice for psoriasis since it was found to be less carcinogenic than UVA and since the development in the late 1980s of a highly efficacious UVB lamp, termed narrow band UVB in the 311nm range.

Vitiligo is a pigmentation disorder, characterised by white patches on the skin. Vitiligo has proven to respond exceptionally well to treatment with Dermaray UV with approximately 80% of patients experiencing an 80% reduction in their condition.

Dermaray Laser is a 100mW red medical laser based on 660nm technology. The Dermaray Laser Low Level Laser Therapy (LLLT) system represents the finest quality and most technologically advanced hand held laser system available today. Unique patent pending technology allows the advanced application of more powerful medical laser modules while offering safety features unique to Dermaray Laser that prevent accidental exposure to the visible laser energy.

Dermaray Laser is designed to be a leading home hair loss treatment solution, wound regeneration, wrinkle and scar reduction and physiotherapy. Low Level Laser Therapy has been proven safe and effective between 1~500mW. Other laser combs and laser brushes are based on 1-5mW lasers that are typically found in laser pointers and video game accessories. Laws of physics dictate that to deliver the required amount of energy required for measurable medical results quickly and efficiently over the scalp, stronger lasers are required as used in Dermaray Laser systems.

Dermaray UV sells for $695 USD and Dermaray Laser for $895 USD.
More information on the Dermaray UV for skin conditions or the hair loss treatment solution Dermaray Laser is available from Nick Balgowan at TCG Industrial, Unit 3, 6 Barnett Court, Morley, WA 6062 Australia. Telephone: (+61) 8 9370 4038 or web: www.dermaray.com

Contact
Nick Balgowan
(+61) 8 9370 4038

###

Read the full story at http://www.prweb.com/releases/dermaray_tcg/hair_loss_treatment/prweb2795534.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Mother and Daughter Create Lead-Free/Safe Bibs and Solve Messy Mealtime Problems
2. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
3. Tips for Parents: Teaching Children to Resolve Conflicts
4. Lipodissolve - Is it Safe???
5. Higher-risk kidneys may help solve organ shortage facing older adults
6. ULLICO Inc. and U.S. Department of Labor Agree to Resolve 5 Year Old ERISA Investigation
7. Will Lipodissolve Continue to Remain Popular?
8. American Society for Aesthetic Plastic Surgery and American Society of Plastic Surgeons Offer Patient Advisory for those Affected by Fig LipoDissolve Closures
9. Manor Care Files Motion with West Virginia Health Care Authority to Dissolve Stay and Issue an Immediate Ruling
10. Researchers solve first structure of a key to intact DNA inheritance
11. Industrial Solvent May Increase Risk for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Solve Skin Conditions and Receive Hair Loss Treatment from Home with New Line of Medical Devices Called Dermaray
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... SEOUL, South Korea , Oct. 4, 2017 /PRNewswire/ ... launched its next-generation CPR training aide "cprCUBE" on Kickstarter. ... of chest compression during cardiac arrests with better efficiency ... patient-mannequins. It also offers real-time feedback on efficacy of ... The crowdfunding campaign has a goal to raise ...
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology: